If you have any other questions or need other size, please get a quote.
Product Description
Documents
Case Study
Custom Reviews
Custom Q&A
Synthetic Use
Related Resources
Specification
Description
BTA-9881, also known as AZD-9639 and MEDI-564, is a viral fusion protein inhibitor potentially for the treatment of respiratory syncytial virus infection.
Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Biological Target
BTA-9881, also known as AZD-9639 and MEDI-564, is a viral fusion protein inhibitor potentially for the treatment of respiratory syncytial virus infection.
Drug Formulation
This drug may be formulated in DMSO
Elemental Analysis
C, 64.54; H, 3.87; Cl, 9.07; N, 14.34; O, 8.19
Exact Mass
390.0884
HS Tariff Code
2934.99.9001
In Vitro Activity
TBD
In Vivo Activity
TBD
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).